Covid 19 Research using Clinical Trials (Home Page)
Report for D000072657: ST Elevation Myocardial Infarction NIH
(Synonyms: ST Elevatio, ST Elevation Myocardia, ST Elevation Myocardial, ST Elevation Myocardial In, ST Elevation Myocardial Infarct, ST Elevation Myocardial Infarction)
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2086 | Percutaneous Coronary Revascularization for STEMI Wiki | 0.71 |
There are 2 clinical trials
Clinical Trials
1 International Study on Acute Coronary Syndromes - ST-segment Elevation Myocardial Infarction COVID 19
The ISACS STEMI COVID-19 has been established in response to the emerging outbreak of COVID-19 to provide a European overview to estimate the real impact of COVID-19 pandemic on treatment and outcome of STEMI by primary angioplasty, and to identify any potential category of patients at risk for delay to treatment or no presentation.
NCT04412655 ST Elevated Myocardial Infarction Undergoing Mechanical Reperfusion Device: Percutaneous Coronary Revascularization for STEMI MeSH:Myocardial Infarction ST Elevation Myocardial Infarction Infarction
HPO:Myocardial infarction
Primary Outcomes
Description: Number of patients undergoing primary angioplasty
Measure: Number of patients undergoing primary angioplasty Time: March April 2019 and 2020
Description: Number of patients undergoing primary angioplasty later 12 hours from symptoms onset;
Measure: Number of patients undergoing primary angioplasty later than 12 hours from symptoms onset; Time: March April 2019 and 2020
Description: Number of patients undergoing primary angioplasty later than 30 minutes from PCI hospital admission
Measure: Number of patients undergoing primary angioplasty later than 30 minutes from PCI hospital admission Time: March April 2019 and 2020
Description: In-Hospital mortality
Measure: In-hospital mortality Time: March April 2019 and 2020
2 Effect of Covid-19 Epidemic on Primary PCI and Prognosis in Patients With Acute STEMI
Primary Outcomes
Description: Number of patients undergoing primary angioplasty
Measure: Number of patients undergoing primary angioplasty Time: March April 2019 and 2020Description: Number of patients undergoing primary angioplasty later 12 hours from symptoms onset;
Measure: Number of patients undergoing primary angioplasty later than 12 hours from symptoms onset; Time: March April 2019 and 2020Description: Number of patients undergoing primary angioplasty later than 30 minutes from PCI hospital admission
Measure: Number of patients undergoing primary angioplasty later than 30 minutes from PCI hospital admission Time: March April 2019 and 2020Description: In-Hospital mortality
Measure: In-hospital mortality Time: March April 2019 and 2020The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic,which provide effective suggestions and strategies for emergency and severe treatment.
NCT04427735 STEMI MeSH:ST Elevation Myocardial Infarction
Primary Outcomes
Description: cardiovascular death, re-infarction, malignant arrhythmia,heart failure, revascularization, and stroke
Measure: MACE (major adverse cardiovascular events) Time: 1 yearDescription: death caused by all reason
Measure: all-cause death Time: 1 year